Welcome to our dedicated page for Research Solutions news (Ticker: RSSS), a resource for investors and traders seeking the latest updates and insights on Research Solutions stock.
Research Solutions, Inc. (NASDAQ: RSSS) is a vertical SaaS and AI company that focuses on research workflows and scientific, technical, and medical (STM) content. This news page aggregates company-issued press releases and other coverage so readers can follow how Research Solutions develops its platforms, reports financial performance, and communicates with investors.
Recent news highlights the company’s positioning as an AI-powered research workflow platform serving academic institutions, life science companies, and research organizations worldwide. Articles describe the growth of its platform revenue and annual recurring revenue, as well as its emphasis on metrics such as Adjusted EBITDA and gross margin as it shifts more of its business toward SaaS and AI solutions.
Readers can expect updates on earnings releases and financial results, where the company reports revenue from its platforms and transactions, discusses ARR trends across B2B and B2C subscriptions, and comments on its progress toward goals such as a Rule of 40 framework. News items also cover product and feature launches, including AI-based offerings like Scite Rankings and the AI Rights add-on for Article Galaxy, which the company describes as addressing compliance needs around AI use of scientific literature.
Additional coverage includes corporate and governance developments, such as management changes, conference presentations, and information about upcoming earnings calls. Investors, researchers, and customers who follow RSSS news can use this page to monitor how the company’s SaaS platforms, AI capabilities, and financial profile evolve over time. For ongoing analysis, users may wish to revisit this page as new press releases and filings are published.
Research Solutions (NASDAQ: RSSS), an AI-powered research workflow platform, has scheduled its fiscal 2025 third quarter earnings conference call for Thursday, May 8, 2025, at 5:00 p.m. ET. The financial results will cover the period ended March 31, 2025.
Key Details:
- President and CEO Roy W. Olivier and CFO Bill Nurthen will host the call
- Dial-in number: 1-203-518-9843
- Conference ID: RESEARCH
- Start Time: 5:00 p.m. ET (2:00 p.m. PT)
Participants should dial in 5-10 minutes before the start time. The call will be broadcast live through the company's investor relations website. A replay will be available after 8:00 p.m. ET until June 8, 2025, accessible via 1-412-317-6671 with replay ID 11158769.
Research Solutions (NASDAQ: RSSS) has announced major enhancements to its AI product, Scite Assistant, introducing an advanced reasoning AI model optimized for scientific research. The company has deployed OpenAI o3-mini with reasoning, which represents a significant upgrade in their AI capabilities.
The new model is specifically designed to think through problems methodically, evaluate multiple approaches, and assess answer accuracy before responding. Key features include customizable reasoning intensity and integration with existing functionalities like journal specification, publication date filtering, and article collection scoping.
According to Chief Strategy Officer Josh Nicholson, the combination of proprietary citation data and exclusive scholarly content access with the new reasoning model delivers superior information synthesis and better identification of nuanced research elements. The enhanced model is currently available to existing enterprise customers, with detailed comparison documents available showcasing the improvements in quality and capabilities.
Research Solutions (NASDAQ: RSSS) has launched a new clearinghouse solution for AI rights to scientific literature, enabling customers to purchase legal rights for using scientific journal content within AI applications. The platform allows for both immediate and retroactive purchases of AI use rights during the checkout process for articles from participating publishers.
The solution addresses key challenges in the AI-enabled R&D market, establishing a licensing framework that benefits both publishers and researchers. Key features include sustainable business models ensuring fair value distribution, legal compliance for R&D organizations, and increased efficiency in research operations through faster searching, analysis, and summarization capabilities.
The platform is designed to serve multiple industries, from pharmaceuticals to engineering, facilitating the integration of AI-driven research methodologies while protecting intellectual property rights. This initiative positions Research Solutions as a bridge between enterprise AI capabilities and scientific content, creating new opportunities for sustainable growth.
Research Solutions (NASDAQ: RSSS) has launched Tables in Scite Assistant, a new AI-powered feature that automatically extracts and analyzes data from scientific literature. The enhancement allows researchers to transform research data into structured insights, significantly reducing the time and effort required for literature reviews.
The Tables functionality enables users to extract data from peer-reviewed literature using AI, with customizable columns to organize research details such as sample size, study limitations, geographic location, and cell type. Early adoption across Medical Affairs, Research & Development, and Clinical Operations teams has shown significant improvements in research efficiency, particularly in competitive intelligence, biomarker identification, and post-market surveillance.
The system offers automated extraction of structured data, enhanced ability to identify biomarkers and clinical outcomes, and streamlined systematic review processes. Users have reported unprecedented levels of engagement with research content and improved efficiency through automated extraction of actionable insights.
Research Solutions (NASDAQ: RSSS) reported fiscal Q2 2025 results with significant growth metrics. Total revenue increased 15.5% to $11.9 million, driven by a 47% rise in platform revenue to $4.6 million. Annual Recurring Revenue (ARR) grew 23% to $19.1 million, including $12.7 million in B2B and $6.4 million in B2C recurring revenue.
The company achieved its best organic performance with 61 net new B2B platform deployments and recorded a nearly $1 million sequential increase in B2C recurring revenue. Gross profit improved 30% with margins expanding 540 basis points to 48.9%. However, the company reported a net loss of $2.0 million ($0.07 per share), primarily due to a $2.4 million charge related to Scite's contingent earnout liability. Adjusted EBITDA reached $963,000, up from $318,000 in the prior year, with trailing twelve-month Adjusted EBITDA of $4.6 million representing a 9.5% margin.
Research Solutions (NASDAQ: RSSS), an AI-powered research workflow platform, has scheduled its fiscal 2025 second quarter financial results conference call for Thursday, February 13, 2025, at 5:00 p.m. ET. The results will cover the period ended December 31, 2024. CEO Roy W. Olivier and CFO Bill Nurthen will host the call, which will include a Q&A session.
The conference call details include a dial-in number (1-203-518-9848) with Conference ID: RESEARCH. A live broadcast and replay will be available through the company's investor relations website. A replay option will be accessible until March 13, 2025, via 1-412-317-6671 with replay ID 11157678.
Research Solutions (NASDAQ: RSSS) reported a 250% year-over-year growth in usage of its AI-powered research platform, Scite, while achieving a 50% reduction in AI-related technology costs. The platform's key features include comprehensive coverage of scientific research through expanded AI rights, full-text search capabilities for both paid and open access content, proprietary citation ranking data, and flexible AI model options including GPT-4o-Mini and Haiku.
The platform's success is demonstrated through its implementation at Clemson University, where it has enhanced research workflows and improved access to scientific literature. The company's unique value proposition lies in its extensive publisher agreements, providing comprehensive access to scholarly content and the ability for enterprise customers to incorporate proprietary research, documents, and in-house AI models.
Research Solutions (NASDAQ: RSSS) has appointed Sefton Cohen as Chief Revenue Officer to accelerate its transformation from a scientific content provider to an AI-enabled research intelligence platform. Cohen brings over 20 years of SaaS experience, previously serving as CRO at Suralink and RapidRatings, where he led a commercial transformation resulting in a $240 million private equity exit. At Research Solutions, Cohen will lead global revenue operations, focusing on scaling platform revenue while maintaining high customer satisfaction. The appointment aligns with the company's recent expansion in AI capabilities, including the launch of literature discovery tools leveraging over 1.2 billion citation statements.
Research Solutions (NASDAQ: RSSS) reported strong fiscal Q1 2025 results with total revenue increasing 20% to $12.0 million. The company achieved significant growth with Platform revenue up 67% to $4.3 million and Annual Recurring Revenue (ARR) rising 60% to $17.6 million. Notable improvements include a record gross margin of 47.9%, net income of $669,000 ($0.02 per diluted share), and Adjusted EBITDA of $1.3 million. The company demonstrated positive cash flow from operations of $0.8 million, marking a substantial improvement from the prior year's $0.8 million burn rate.
Research Solutions (NASDAQ: RSSS), an AI-powered research workflow platform, has scheduled its fiscal 2025 first quarter financial results conference call for November 14, 2024, at 5:00 p.m. ET. The company will release its financial results for the quarter ended September 30, 2024, after market close on the same day. CEO Roy W. Olivier and CFO Bill Nurthen will host the call, which will include a Q&A session. The call will be accessible via dial-in and webcast, with a replay available until December 14, 2024.